Starting from the identified JAK1 mutation, we compared the expression of different BCL2-related and JAK/STAT pathway genes between our patient and a cohort of adult JAK1wt B-ALL (both TN and Ph + cases) and healthy donors in order to identify markers of response. Here, JAK1 is linked to acute lymphoblastic leukemia.